PDCD1 and non-small cell lung carcinoma: We then calculated both iHet and iHet_rev scores using pre-therapy RNA-seq data generated from a cohort of 27 NSCLC patients treated with anti-PD-1/PD-L1 (19 non-responders and 8 responders).60